Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Celularity (CELU) Revenue (2020 - 2025)

Celularity (CELU) has disclosed Revenue for 6 consecutive years, with $5.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Revenue fell 43.16% to $5.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $23.1 million, a 52.0% decrease, with the full-year FY2024 number at $54.2 million, up 138.11% from a year prior.
  • Revenue was $5.3 million for Q3 2025 at Celularity, down from $5.7 million in the prior quarter.
  • In the past five years, Revenue ranged from a high of $14.7 million in Q1 2024 to a low of $688000.0 in Q4 2024.
  • A 5-year average of $6.4 million and a median of $4.9 million in 2021 define the central range for Revenue.
  • Peak YoY movement for Revenue: surged 1604.53% in 2021, then tumbled 94.32% in 2024.
  • Celularity's Revenue stood at $4.9 million in 2021, then fell by 14.97% to $4.1 million in 2022, then surged by 193.34% to $12.1 million in 2023, then crashed by 94.32% to $688000.0 in 2024, then soared by 668.02% to $5.3 million in 2025.
  • Per Business Quant, the three most recent readings for CELU's Revenue are $5.3 million (Q3 2025), $5.7 million (Q2 2025), and $11.4 million (Q1 2025).